Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan

Masanari Kuwabara1, Mayumi Yashiro, Kazuhiko Kotani

  • 1Department of Public Health, Jichi Medical University, Shimotsuke, Tochigi; Department of Cardiology, Toranomon Hospital, Tokyo, Japan.

Journal of Epidemiology
|February 27, 2015
PubMed

Insights

Early identification of cardiac lesions in Kawasaki disease is crucial. Male sex, older age, elevated platelet count, low albumin, and high C-reactive protein (CRP) are key risk factors in the initial disease phase.

Area of Science:

  • Pediatric Cardiology
  • Rheumatology
  • Infectious Diseases

Background:

  • Kawasaki disease can lead to cardiac lesions like coronary dilatation and aneurysms.
  • Most research focuses on later stages, neglecting early indicators.
  • This study investigates early-phase cardiac lesion risk factors.

Purpose of the Study:

  • To identify factors associated with cardiac lesions in the initial phase of Kawasaki disease.
  • To correlate laboratory data with cardiac manifestations in early Kawasaki disease.
  • To inform early risk assessment and management strategies.

Main Methods:

  • Cross-sectional study of 23,155 patients from Japan's 22nd nationwide Kawasaki disease survey (2011-2012).
  • Analysis included patients within 7 days of symptom onset, excluding recurrent cases.
  • Laboratory data analyzed: white blood cell count, platelet count, serum albumin, and C-reactive protein (CRP).

Main Results:

  • Cardiac lesions occurred in 984 patients (3.4%), primarily coronary dilatation (764).
  • Factors for coronary dilatation: male sex (OR 1.73), older age (OR 1.03), higher platelets (OR 1.006), lower albumin (OR 0.66), higher CRP (OR 1.02).
  • Coronary aneurysms linked to higher platelets (OR 1.01) and lower albumin (OR 0.34). Valvular lesions associated with age (OR 0.98) and higher CRP (OR 1.05).

Conclusions:

  • Male sex, older age, elevated platelet count, low serum albumin, and high CRP are significant predictors of cardiac lesions in early Kawasaki disease.
  • These factors aid clinicians in assessing cardiac risk during the initial disease phase.
  • Early identification of these factors can guide timely intervention and management.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
468
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
572
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
869
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K